Arkadios Wealth Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Arkadios Wealth Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,500	Closed	-$5K	–	1930
2021 Q3	$5K	Hold	1,500	–	–	﹤0.01%	1627
2021 Q2	$6K	Hold	1,500	–	–	﹤0.01%	1701
2021 Q1	$6K	Hold	1,500	–	–	﹤0.01%	1338
2020 Q4	$5K	Hold	1,500	–	–	﹤0.01%	1138
2020 Q3	$5.05K	Hold	1,500	–	–	﹤0.01%	846
2020 Q2	$3.98K	Hold	1,500	–	–	﹤0.01%	806
2020 Q1	$3.54K	Hold	1,500	–	–	﹤0.01%	844
2019 Q4	$5.37K	Buy	+1,500	New	+$6.14K	﹤0.01%	694

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Arkadios Wealth Advisors's ATRS Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 1,500 shares — an estimated $5K sold.

Arkadios Wealth Advisors first reported a position in ATRS in Q4 2019 and held it in 8 quarters. The position peaked at $6K in Q2 2021. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

Arkadios Wealth Advisors reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
Arkadios Wealth Advisors sold 1,500 Antares Pharma, Inc. shares in Q4 2021, an estimated $5K.
Arkadios Wealth Advisors first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 8 quarters.
Arkadios Wealth Advisors's Antares Pharma, Inc. position peaked at $6K in Q2 2021.
162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.